CD177 and chronic recurrent multifocal osteomyelitis: Possible explanations for reduced CCL11/eotaxin serum levels in patients with here included alternative diagnoses and CRMO remain hypothetical and include “uptake,” recruitment to sites of inflammation, or cell-surface receptor binding of CCL11/eotaxin (32, 33).